Get started
Author

Helene Duret

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
2013 · Yuting Ma, Sandy Adjemian, et al. · Immunity · 700
Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy
2011 · John Stagg, Sherene Loi, et al. · Proceedings of the National Academy of Sciences · 496
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
2011 · John Stagg, Upulie Divisekera, et al. · Cancer Research · 401
Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
2011 · Stephen R. Mattarollo, Sherene Loi, et al. · Cancer Research · 334
PDF
NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases
2012 · Melvyn T. Chow, Jaclyn Sceneay, et al. · Cancer Research · 182
CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
2013 · Yuting Ma, Stephen R. Mattarollo, et al. · Cancer Research · 137
TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells
2013 · Annamaria Biroccio, Julien Cherfils-Vicini, et al. · Nature Cell Biology · 134
Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State
2012 · Michele W. L. Teng, Matthew D. Vesely, et al. · Cancer Research · 118
CD3bright signals on γδ T cells identify IL‐17A‐producing Vγ6Vδ1+ T cells
2014 · C Paget, M T Chow, et al. · Immunology and Cell Biology · 80
PDF
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
2012 · Stephen R. Mattarollo, Alison C. West, et al. · Blood · 80
PDF
Role of γδ T Cells in α-Galactosylceramide–Mediated Immunity
2012 · Christophe Paget, Melvyn T Chow, et al. · The Journal of Immunology · 53
Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
2011 · Michele W.L. Teng, Bianca von Scheidt, et al. · Cancer Research · 51
Transient Foxp3+ regulatory T‐cell depletion enhances therapeutic anticancer vaccination targeting the immune‐stimulatory properties of NKT cells
2012 · Stephen R Mattarollo, Kim Steegh, et al. · Immunology and Cell Biology · 46
Type I NKT ‐cell‐mediated TNF ‐α is a positive regulator of NLRP 3 inflammasome priming
2014 · Melvyn T. Chow, Helene Duret, et al. · European Journal of Immunology · 24
PDF
Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma
2012 · Christophe Paget, Helene Duret, et al. · OncoImmunology · 14
PDF
CD3(bright) signals on gamma delta T cells identify IL-17A-producing V gamma 6V delta 1( ) T cells
2015 · Christophe Paget, MT Chow, et al. · Immunology and Cell Biology · 6
抗il-23単クローン抗体は標的療法または Il-2との併用で相乗作用を示し,腫瘍増殖と転移を抑制する
2011 · W L Teng Michele, Von Scheidt Bianca, et al. · Cancer Research · 1
Data from CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
2023 · Yuting Ma, Stephen R. Mattarollo, et al.
Data from CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
2023 · John Stagg, Upulie Divisekera, et al.
Data from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
2023 · Michele W.L. Teng, Bianca von Scheidt, et al.
Supplementary Table 1 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
2023 · Stephen R. Mattarollo, Sherene Loi, et al.
Supplementary Methods, Figure Legends 1-2 from Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases
2023 · Michele W.L. Teng, Bianca von Scheidt, et al.
PDF
Supplementary Figure 7 from NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases
2023 · Melvyn T. Chow, Jaclyn Sceneay, et al.
PDF
Supplementary Figure 2 from NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases
2023 · Melvyn T. Chow, Jaclyn Sceneay, et al.
Supplementary Table 1 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
2023 · Stephen R. Mattarollo, Sherene Loi, et al.
PDF
Works count: 97
Citation count: 2,857
H-index: 14
I10-index: 15
Year
Topic
Type